Elizabeth E. Sugg
48 works · 1,322 citations · h-index 19
Top works
- Allele-specific activation of genetically engineered receptors.
- Determination of the three-dimensional structure of iberiotoxin in solution by proton nuclear magnetic resonance spectroscopy
- Rapid optimization of enzyme substrates using defined substrate mixtures.
- Synthesis and structural characterization of charybdotoxin, a potent peptidyl inhibitor of the high conductance Ca2(+)-activated K+ channel.
- Influence of pseudoallylic strain on the conformational preference of 4-methyl-4-phenylpipecolic acid derivatives
- Optimization of 3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines as Potent, Orally Active CCK-A Agonists
- Synthetic charybdotoxin-iberiotoxin chimeric peptides define toxin binding sites on calcium-activated and voltage-dependent potassium channels
- Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity. 1. Optimization of the Agonist “Trigger”
- Synthesis and Evaluation of Potent and Selective β3 Adrenergic Receptor Agonists Containing Acylsulfonamide, Sulfonylsulfonamide, and Sulfonylurea Carboxylic Acid Isosteres
- An Improved Synthesis and Resolution of 3-Amino-1,3-dihydro-5-phenyl-2H- 1,4-benzodiazepin-2-ones
- Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity (II): Optimization of the C3 Amino Substituent
- 3-[2-(N-Phenylacetamide)]-1,5-benzodiazepines: Orally Active, Binding Selective CCK-A Agonists
- Proton n.m.r. investigation of conformational influence of penicillamine residues on the disulfide ring system of opioid receptor selective Somatostatin derivatives
- Biarylaniline Phenethanolamines as Potent and Selective β3Adrenergic Receptor Agonists
- Novel Benzodiazepine Photoaffinity Probe Stereoselectively Labels a Site Deep within the Membrane-Spanning Domain of the Cholecystokinin Receptor
- Structurally similar small molecule photoaffinity CCK-A agonists and antagonists as novel tools for directly probing 7TM receptor-ligand interactions
- 3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A Agonists That Demonstrate Oral Activity as Satiety Agents
- Immunogenicity of synthetic HIV-1 gp120 V3-loop peptide-conjugate immunogens
- Proton n.m.r. spectroscopic evidence for sulfur‐aromatic interactions in peptides
- D ‐Isomeric replacements within the 6–9 core sequence of ac‐[Nle4]‐α‐MSH4–11‐NH2: A topological model for the solution conformation of α‐melanotropin